Published in Diagn Immunol on January 01, 1985
Infection in organ-transplant recipients. N Engl J Med (1998) 6.49
Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol (1981) 3.71
Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63
Simplified silver-plating stain for flagella. J Clin Microbiol (1977) 3.37
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med (1994) 2.54
Clinical, microbiologic and therapeutic aspects of purulent pericarditis. Am J Med (1975) 2.46
Infective endocarditis--1973. Prog Cardiovasc Dis (1974) 2.42
Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic. N Engl J Med (1978) 2.33
Identification of gram-negative bacilli using the Autobac IDX. Diagn Microbiol Infect Dis (1985) 2.32
Characterization of glass adherent human mononuclear cells. J Immunol (1973) 2.22
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation (1981) 2.22
Hepatic abscess: changes in clinical, bacteriologic and therapeutic aspects. Am J Med (1974) 2.21
Characterization of responding cells in oxidative mitogen stimulation. II. Identification of an Ia-bearing adherent accessory cell. J Immunol (1980) 2.19
Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun (1989) 2.12
Production of colony-stimulating factor in mitogen-stimulated lymphocyte cultures. J Immunol (1974) 2.02
The release of four mediators of immediate hypersensitivity from human leukemic basophils. J Immunol (1975) 1.92
Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med (1990) 1.92
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures. Cancer (1977) 1.83
Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med (1981) 1.77
Evaluation of the acid-fast smear. J Clin Microbiol (1976) 1.75
BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation (2001) 1.75
Evaluation of an automated, computerized system (automicrobic system) for Enterobacteriaceae identification. J Clin Microbiol (1981) 1.72
Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. J Nucl Med (1991) 1.65
A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum (1982) 1.62
Endobronchial disease and racial differences in pulmonary sarcoidosis. Chest (1997) 1.57
Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob Agents Chemother (1993) 1.55
A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum (1982) 1.51
Reed-Sternberg-like cells in infectious mononucleosis. Lancet (1969) 1.49
Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med (1986) 1.48
"Reed-Sternberg cells" in infectious mononucleosis? Am J Clin Pathol (1972) 1.46
Adverse reactions to duck embryo rabies vaccine. Range and incidence. Ann Intern Med (1973) 1.44
Single-dose amoxicillin therapy for urinary tract infection. Multicenter trial using antibody-coated bacteria localization technique. JAMA (1980) 1.43
Intraarticular corticosteroid injections: should we rest the joints? Arthritis Care Res (1989) 1.41
Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation (1977) 1.40
Immunoglobulin inclusions in non-Hodgkin's lymphomas. Am J Clin Pathol (1978) 1.40
Identification of Streptococcus pneumoniae by the Phadebact coagglutination test. J Clin Microbiol (1982) 1.40
Transient stress lymphocytosis during crisis of sickle cell anemia and emergency trauma and medical conditions. An immunophenotyping study. Arch Pathol Lab Med (1990) 1.39
The therapeutic prescription for the transplant patient. Transpl Infect Dis (2002) 1.39
In search of the hot appendix--a clinician's view of inflammation imaging. J Nucl Med (1990) 1.38
A comparison of four commercial systems for the identification of nonfermentative gram-negative bacilli. Am J Clin Pathol (1980) 1.37
Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases. Semin Hematol (1978) 1.37
Neurologic complications of bacterial endocarditis. Medicine (Baltimore) (1978) 1.36
Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology (1995) 1.35
Automatic gram-staining with the microstainer II. Health Lab Sci (1976) 1.33
A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol (1978) 1.33
Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS. J Clin Microbiol (1993) 1.33
Reactive lymphoid hyperplasia with single class (monoclonal) surface immunoglobulin. Am J Clin Pathol (1983) 1.32
Evaluation of a rapid method to exclude the presence of certain enteric pathogens in stool specimens. J Clin Microbiol (1984) 1.32
Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation (1985) 1.29
Central nervous system infection in the chronically immunosuppressed. Medicine (Baltimore) (1982) 1.27
Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1993) 1.27
Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: a new concept for absolute T cell subset determinations. Cytometry (1995) 1.27
Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med (1976) 1.26
Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung. J Clin Invest (1978) 1.26
Ethnicity and physician-older patient communication about alternative therapies. J Altern Complement Med (2001) 1.25
Infection in the renal transplant recipient. Am J Med (1981) 1.25
A case of human rabies in Kansas: epidemiologic, clinical, and laboratory considerations. J Infect Dis (1970) 1.24
Antidepressant prescribing to Hispanic and non-Hispanic white patients in primary care. Ann Pharmacother (2001) 1.24
Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med (1983) 1.23
Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation (1996) 1.22
Single-dose therapy with trimethoprim-sulfamethoxazole for urinary tract infection in women. Rev Infect Dis (1982) 1.21
The use of serial carcinoembryonic antigen determinations to predict recurrence of carcinoma of the colon and the time for a second-look operation. Surg Gynecol Obstet (1978) 1.20
Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation (1984) 1.20
The morphologic and cytochemical demonstration of lysosomes in lymphocytes incubated with phytohemagglutinin by electron microscopy. Lab Invest (1965) 1.19
Standardization of absolute CD4+ lymphocyte counts across laboratories: an evaluation of the Ortho CytoronAbsolute flow cytometry system on normal donors. Cytometry (1995) 1.18
Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med (1983) 1.18
Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients. Transplantation (1981) 1.18
Hepatitis C virus and organ transplantation. Transplantation (1996) 1.17
Accumulation of immunoglobulin G at focal sites of inflammation. Eur J Nucl Med (1992) 1.17
Group identification of streptococci. Evaluation of three rapid agglutination methods. Am J Clin Pathol (1981) 1.16
Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation (1992) 1.16
Production of colony-stimulating factor in mixed leucocyte cultures. Immunology (1974) 1.16
Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma. Clin Immunol Immunopathol (1976) 1.15
Physician-patient communication about over-the-counter medications. Soc Sci Med (2001) 1.15
The spectrum of Salmonella infection. Infect Dis Clin North Am (1988) 1.13
Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential. Cancer Res (1987) 1.12
Concentrations of phosphorylated zidovudine (ZDV) in patient leukocytes do not correlate with ZDV dose or plasma concentrations. Ther Drug Monit (1991) 1.11
From the National Institutes of Health. Summary of a workshop on cytomegalovirus infections during organ transplantation. J Infect Dis (1979) 1.11
Eosinophilic gastroenteritis with obstruction. Immunological studies of seven patients. Gastroenterology (1978) 1.11
Structure and copy number of gene clusters related to the pap P-adhesin operon of uropathogenic Escherichia coli. Infect Immun (1989) 1.09
Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med (1995) 1.09
Primary cytomegalovirus infection following cardiac transplantation in a murine model. Transplantation (1984) 1.09
Trimethoprim-sulfamethoxazole. N Engl J Med (1980) 1.08
Periodate-induced lymphocyte transformation. IV. Mitogenic effect of NaIO4 treated lymphocytes upon autologous lymphocytes. J Immunol (1974) 1.08
Comparative ultraviolet sensitivity of regeneration in the genus Blepharisma. J Protozool (1965) 1.08
Regional perfusion, oxygen metabolism, blood volume and immunoglobulin G accumulation at focal sites of infection in rabbits. Eur J Nucl Med (1992) 1.08
TRransformation of human lymphocytes by sodium periodate. Lancet (1972) 1.08
Antibody Formation in Embryos. Science (1963) 1.08
The circadian rhythm in photosynthesis in Acetabularia in the presence of actinomycin D, puromycin, and chloramphenicol. J Gen Physiol (1967) 1.07
Preemptive therapy in immunocompromised hosts. N Engl J Med (1991) 1.07
Invasive aspergillus infection: possible non-ward common source within the hospital environment. J Hosp Infect (1989) 1.07
Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects. Pharmacotherapy (1984) 1.06
Defective DNA repair in Fanconi's anaemia. Nature (1974) 1.05
In vitro measurement of phosphorylated zidovudine in peripheral blood leucocytes. Ther Drug Monit (1990) 1.05
The effect of infection on T lymphocyte subpopulations: a preliminary report. Int J Immunopharmacol (1981) 1.04
Neurologic complications following the treatment of human Babesia microti infection with diminazene aceturate. Am J Trop Med Hyg (1979) 1.04
Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG: comparison with indium-111-DTPA-IgG. J Nucl Med (1996) 1.04